Biotechnology Based Chemicals Companies, Investment and Capital Allocation

What are the Latest Offerings in the Biotechnology Based Chemicals Market Companies?

BASF

Headquarters: Ludwigshafen, Germany
Offerings: Produces enzymes, biopolymers, biosurfactants, and specialty bio-based chemicals used in pharmaceuticals, agriculture, personal care, and industrial applications.

Braskem S.A.

Headquarters: Brazil
Offerings: Leading producer of biopolymers such as Green PE (polyethylene from sugarcane ethanol) and other renewable chemical solutions.

Cargill, Incorporated

Headquarters: Minnesota, USA
Offerings: Develops bioindustrial and renewable chemical solutions from biomass (such as corn and soy), including bio-based intermediates and performance ingredients for industrial applications.

Champlor (Valtris Specialty Chemicals)

Headquarters: United Kingdom
Offerings: Provides specialty chemical intermediates and performance additives, including bio-derived specialty ingredients used in coatings, plastics, and industrial applications.

dsm-firmenic

Headquarters: Netherlands / Kaiseraugst, Switzerland
Offerings: Focuses on sustainable bio-based specialty chemicals, nutritional ingredients, and biotechnology-driven materials for food, personal care, and industrial uses.

DuPont de Nemours Inc.

Headquarters: Delaware, USA
Offerings: Produces industrial biotechnology solutions, bio-based materials, enzymes, and specialty proteins for sectors such as healthcare and advanced materials.

Evonik Industries AG

Headquarters: Essen, Germany
Offerings: Supplies bio-based specialty chemicals, amino acids, biosurfactants, and advanced intermediates used across healthcare, nutrition, and industrial markets.

Value Chain Analysis

R&D

• Research and development centers on leveraging microorganisms, enzymes, and biological pathways to produce chemicals sustainably, reducing reliance on fossil-based resources.
• Key focus areas include genetic modification, synthetic biology, biocatalysis, and advanced fermentation to enhance yield, efficiency, and scalability.
• These innovations support the production of bio-alcohols, bio-organic acids, and high-value specialty ingredients for pharmaceuticals, food & beverage, agriculture, and industrial applications.
• Key Players: BASF, DSM-Firmenich, DuPont, Evonik Industries, Corbion

Clinical Trials

• Clinical trials for biotechnology-based chemicals are conducted through a structured, multi-phase process to evaluate safety, efficacy, dosage, and immunogenicity.
• Due to their complex biological composition, biologics require additional testing, specialized manufacturing controls, and strict regulatory oversight compared to conventional drugs.
• Regulatory agencies closely monitor consistency, stability, and long-term effects throughout all trial phases.
• Key Players: Roche, Pfizer, Novartis, Amgen, Johnson & Johnson, Sanofi

Formulation

• Formulation involves integrating the biologically active component, especially protein-based ingredients, with carefully selected excipients to maintain stability, safety, and therapeutic effectiveness.
• The process includes steps such as stabilization, preservation, and delivery optimization to protect sensitive biological molecules during storage and use.
• Strict quality control and regulatory compliance are essential to ensure product consistency and patient safety.
• Key Players: Lonza, Thermo Fisher Scientific, Catalent, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies

Market Forecast

The global biotechnology based chemicals market size was estimated at USD 109.53 billion in 2025 and is predicted to increase from USD 120.09 billion in 2026 to approximately USD 274.93 billion by 2035, expanding at a CAGR of 9.64% from 2026 to 2035.

Major Investments in the Biotechnology Based Chemicals Market

• In December 2025, two green biotech firms received £10 million from the Scottish/UK governments to build bio-chemical production plants at Grangemouth.
• In September 2025, the UK’s Xampla raised $14 million to expand biodegradable bio-chemical packaging solutions.
• In May 2025, Biomaterials companies, many producing bio-based chemicals, received $392 million in investments, signaling strong investor interest in sustainable chemical platforms.

Partner with our experts to explore the Biotechnology Based Chemicals Market at sales@towardshealthcare.com